Becker’s Orthopedic & Spine Review reports that Stryker reported $2.05 billion in net sales, a 12 percent increase over last year, according to a company news release.
The company can attribute its financial success to product line sales, including the sale of reconstructive products, MedSurg products and neurotechnology and spine products. There was a higher recorded shipment of hip, trauma and extremities implant systems, which offset lower shipments of knee and other implant systems